Clinical Practice Guidelines (CPG) on EBMonFHIR
0.8.0-snapshot - ci-build
Clinical Practice Guidelines (CPG) on EBMonFHIR - Local Development build (v0.8.0-snapshot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Official URL: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/example/covid19-ventilated-patients-dexamethasone-application-plan | Version: 4.0 | |||
Active as of 2021-12-12 | Responsible: CPGonEBMonFHIR | Computable Name: Dexamethasone_Application |
Application of Dexamethasone: 6 mg once per day for 10 days p.o. or i.v. for ventilated COVID-19 patients
Generated Narrative: PlanDefinition
ResourcePlanDefinition "COVID19VentilatedPatientsDexamethasoneApplicationPlan"
Profile: Recommendation Plan
knowledgeCapability: computable
knowledgeRepresentationLevel: structured
partOf: Dexamethasone Application
Action Combination Method
url
method
value: Exactly (Action Combination Method#exactly)
url
threshold
value: 1
url: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/example/covid19-ventilated-patients-dexamethasone-application-plan
version: 4.0
name: Dexamethasone_Application
title: Dexamethasone Application in ventilated COVID-19 patients
type: ECA Rule (PlanDefinitionType#eca-rule)
status: active
experimental: true
subject: Population_COVID19_Ventilated
date: 2021-12-12
publisher: CPGonEBMonFHIR
description: Application of Dexamethasone: 6 mg once per day for 10 days p.o. or i.v. for ventilated COVID-19 patients
action
code: Administration of substance (procedure) (SNOWMED CT#432102000)
definition: DexamethasoneApplicationActionOral
action
code: Administration of substance (procedure) (SNOWMED CT#432102000)
definition: DexamethasoneApplicationActionIntravenous